Suchergebnisse - "Nechushtan, Hovav"

PubPharm (142)

1

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma : Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Motzer, R. | Porta, C. | Eto, M. | +134

2

Outcomes of extracranial stereotactic body radiation therapy for induced oligometastatic non-small cell lung cancer on novel systemic therapy

enthalten in: Translational lung cancer research | 2024

von Tsur, E. | Blumenfeld, P. | Rottenberg, Y. | +9

3

Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer

enthalten in: JCO precision oncology | 2024

von Christopoulos, P. | Harel, M. | McGregor, K. | +34

4

Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions

enthalten in: The New England journal of medicine | 2023

von Zhou, C. | Tang, K. | Cho, B. | +126

CommentIn: Cancer Discov. 2023 Dec 12;13(12):OF9. - PMID 37878779

5

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Nisman, B. | Oleinikov, K. | Nechushtan, H. | +7

CommentOn: J Thorac Oncol. 2023 Nov;18(11):e138-e139. - PMID 37879774

6

First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion-Positive NSCLC

enthalten in: The New England journal of medicine | 2023

von Zhou, C. | Solomon, B. | Loong, H. | +122

CommentIn: Cancer Discov. 2023 Dec 12;13(12):OF8. - PMID 37874126

7

Clinical Characteristics, Response to Platinum-Based Chemotherapy and Poly (Adenosine Phosphate-Ribose) Polymerase Inhibitors in Advanced Lung Cancer Patients Harboring BRCA Mutations

enthalten in: Cancers | 2023

von Arnon, J. | Tabi, M. | Rottenberg, Y. | +10

8

Neoadjuvant Osimertinib Followed by Sequential Definitive Radiation Therapy and/or Surgery in Stage III Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer : An Open-Label, Single-Arm, Phase 2 Study

enthalten in: International journal of radiation oncology, biology, physics | 2023

von Peled, N. | Roisman, L. | Levison, E. | +22

CommentIn: Int J Radiat Oncol Biol Phys. 2023 Sep 1;117(1):115-117. - PMID 37574235

9

ANTIBODY SEQUENCES OF THREE ANTIBODY CANDIDATES TARGETING HUMAN LYMPHOCYTE ANTIGEN 6 FAMILY MEMBER K (LY6K)

enthalten in: Europäisches Patentamt | 2023

von MACARY PAUL | SUTER MANUEL | LANG SI MIN | +2

10

ANTIBODY SEQUENCES OF THREE ANTIBODY CANDIDATES TARGETING HUMAN LYMPHOCYTE ANTIGEN 6 FAMILY MEMBER K (LY6K)

enthalten in: Europäisches Patentamt | 2023

von MACARY PAUL | SUTER MANUEL | LANG SI MIN | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]